These Numbers Show Favorable Signs for Carisma Therapeutics Inc (CARM)

Carisma Therapeutics Inc (NASDAQ: CARM) is 7.83% higher on its value in year-to-date trading and has touched a low of $0.14 and a high of $1.90 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CARM stock was last observed hovering at around $0.55 in the last trading session, with the day’s loss setting it -0.1%.

Currently trading at $0.45, the stock is 57.51% and 90.88% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 12.56 million and changing -17.62% at the moment leaves the stock -22.10% off its SMA200. CARM registered -63.58% loss for a year compared to 6-month loss of -34.81%.

The stock witnessed a 134.11% gain in the last 1 month and extending the period to 3 months gives it a 9.88%, and is 132.90% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 96.99% over the week and 39.57% over the month.

Carisma Therapeutics Inc (CARM) has around 46 employees, a market worth around $18.87M and $19.96M in sales. Profit margin for the company is -254.28%. Distance from 52-week low is 218.70% and -76.23% from its 52-week high.

The EPS is expected to grow by 50.00% this year.

Carisma Therapeutics Inc (CARM) Top Institutional Holders

The shares outstanding are 41.79M, and float is at 21.12M with Short Float at 3.29%.

The top institutional shareholder in the company is VANGUARD GROUP INC with over 1.45 million shares valued at $2.2 million. The investor’s holdings represent 3.4861% of the CARM Shares outstanding. As of 2024-06-30, the second largest holder is TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA with 1.25 million shares valued at $1.9 million to account for 3.014 of the shares outstanding. The other top investors are TPG GP A, LLC which holds 0.84 million shares representing 2.0269% and valued at over $1.28 million, while BLACKROCK INC. holds 1.7091 of the shares totaling 0.71 million with a market value of $1.08 million.

Carisma Therapeutics Inc (CARM) Insider Activity

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.